Mirioglu S, Cinar S, Uludag O, Gurel E, Varelci S, Ozluk Y
Turk J Med Sci. 2024; 54(2):391-400.
PMID: 39050398
PMC: 11265893.
DOI: 10.55730/1300-0144.5804.
Huang B, Feng D, Niu X, Huang W, Hao S
Sci Rep. 2023; 13(1):11047.
PMID: 37422503
PMC: 10329644.
DOI: 10.1038/s41598-023-38092-y.
Saadati N, Miri M
Caspian J Intern Med. 2023; 14(2):231-236.
PMID: 37223281
PMC: 10201120.
DOI: 10.22088/cjim.14.2.231.
Sung W, Lin Y, Hwang D, Lin C, Li R, Tseng C
Diagnostics (Basel). 2022; 12(12).
PMID: 36553013
PMC: 9776498.
DOI: 10.3390/diagnostics12123006.
Xiong D, Shi X, Han M, Zhang X, Wu N, Sheng X
Front Pharmacol. 2022; 13:982238.
PMID: 36176425
PMC: 9514453.
DOI: 10.3389/fphar.2022.982238.
The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.
Tizaoui K, Yang J, Lee K, Kim J, Kim M, Yoon S
Int J Biol Sci. 2022; 18(9):3731-3746.
PMID: 35813465
PMC: 9254466.
DOI: 10.7150/ijbs.67587.
Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study.
Shiratori-Aso S, Nakazawa D, Nishio S, Ueda Y, Eguchi M, Yokoyama A
Front Med (Lausanne). 2022; 9:827388.
PMID: 35280914
PMC: 8914032.
DOI: 10.3389/fmed.2022.827388.
Levels of the macrophage migration inhibitory factor and polymorphisms in systemic lupus erythematosus: a meta-analysis.
Sam N, Guan S, Wang P, Li X, Wang D, Pan H
Arch Med Sci. 2021; 17(5):1232-1240.
PMID: 34522252
PMC: 8425225.
DOI: 10.5114/aoms.2019.85459.
Basophils as a potential marker of lupus nephritis by flow cytometry.
Jiang Y, Chen J, Zhao Y, Liu Y, Xu H, Mo X
Future Sci OA. 2021; 7(5):FSO690.
PMID: 34046192
PMC: 8147755.
DOI: 10.2144/fsoa-2020-0212.
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
Bruschi M, Moroni G, Sinico R, Franceschini F, Fredi M, Vaglio A
Rheumatology (Oxford). 2020; 60(7):3176-3188.
PMID: 33374003
PMC: 8487649.
DOI: 10.1093/rheumatology/keaa767.
The Network of Inflammatory Mechanisms in Lupus Nephritis.
Nozaki Y
Front Med (Lausanne). 2020; 7:591724.
PMID: 33240910
PMC: 7677583.
DOI: 10.3389/fmed.2020.591724.
Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Sam N, Zhang Q, Li B, Li X, Wang D, Pan H
Clin Rheumatol. 2020; 39(6):1725-1736.
PMID: 32090304
DOI: 10.1007/s10067-020-04985-w.
Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers.
Monzavi S, Alirezaei A, Shariati-Sarabi Z, Tavakol Afshari J, Mahmoudi M, Dormanesh B
Inflammopharmacology. 2018; 26(5):1175-1182.
PMID: 29987550
DOI: 10.1007/s10787-018-0512-y.
Laboratory Standards in the Diagnosis and Therapy Monitoring of Systemic Lupus Erythematosus.
Sipka S
EJIFCC. 2018; 17(3):110-117.
PMID: 29760639
PMC: 5938686.
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.
Martin M, Smolag K, Bjork A, Gullstrand B, Okroj M, Leffler J
Arthritis Res Ther. 2017; 19(1):266.
PMID: 29208014
PMC: 5717799.
DOI: 10.1186/s13075-017-1470-2.
Characterization and classification of lupus patients based on plasma thermograms.
Garbett N, Brock G, Chaires J, Mekmaysy C, DeLeeuw L, Sivils K
PLoS One. 2017; 12(11):e0186398.
PMID: 29149219
PMC: 5693473.
DOI: 10.1371/journal.pone.0186398.
Low level of circulating basophil counts in biopsy-proven active lupus nephritis.
Liang P, Tang Y, Lin L, Zhong H, Yang H, Zeng Y
Clin Rheumatol. 2017; 37(2):459-465.
PMID: 28988406
DOI: 10.1007/s10067-017-3858-4.
Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
Salem M, Taha H, Abd El-Fattah El-Feqi M, Eesa N, Mohamed R
Z Rheumatol. 2016; 77(1):71-77.
PMID: 27619369
DOI: 10.1007/s00393-016-0184-1.
International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith E, Jorgensen A, Midgley A, Oni L, Goilav B, Putterman C
Pediatr Nephrol. 2016; 32(2):283-295.
PMID: 27590021
PMC: 5203828.
DOI: 10.1007/s00467-016-3485-3.
Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
Chuang H, Chen Y, Hung W, Li J, Chen D, Lan J
Oncotarget. 2016; 7(36):57593-57605.
PMID: 27557500
PMC: 5295375.
DOI: 10.18632/oncotarget.11419.
